NB Watts, JP Bilezikian, K Usiskin… - The Journal of …, 2016 - academic.oup.com
Context: Canagliflozin is a sodium glucose cotransporter 2 inhibitor developed to treat type 2
diabetes mellitus (T2DM). Objective: The purpose of this study was to describe the effects of …